Huons Meditech to showcase at Healthcare Trade Fair ‘Hospitalar 2025’ in Brazil
Huons Meditech to showcase at Healthcare Trade Fair ‘Hospitalar 2025’ in Brazil
- Expanding to Latin America with ‘ASADAL-M1’ and ‘Dermashine Pro’ -
▲ Huons Meditech participated the premier healthcare trade fair 'Hospitalar 2025' held in São Paulo, Brazil.
Huons Group’s medical device subsidiary, Huons Meditech, aims to expand its reach to Latin America while spotlighting its medical devices to Latin American audiences at a premier healthcare event in Brazil.
Huons Meditech (CEO Lee Jin-suk) announced that it had participated in this year’s healthcare trade fair ‘Hospitalar 2025’, held this week from May 20 to 23 (local time) in São Paulo, Brazil.
Hospitalar is the largest business and healthcare event in Latin America. Established as the leading platform for connecting professionals and companies in the healthcare sector, Hospitalar serves as a bridgehead for expanding its reach to Latin America including Brazil.
Huons Meditech showcased extracorporeal shock wave lithotripter (ESWL) ‘ASADAL-M1’ and automatic mesotherapy injector ‘Dermashine Pro’ at the exhibition booth.
Huons Meditech attracted much attention from visitors on ‘ASADAL-M1’. It is an ESWL for fragmentation of urinary tract stones, which received approvals from both FDA and EU (CE marking). In addition, there is less pain and less recovery time required in the procedure using ‘ASADAL-M1’ compared to the other surgical procedures, which allows the patient to return to daily life as soon as possible after the procedure.
The company also received spotlight on ‘Dermashine Pro’ at the exhibition for catering to the needs of the Latin American beauty. ‘Dermashine Pro’ is an aesthetic medical device with a CE marking, which features precise drug infusion function and user-friendly design interface.
At ‘Hospitalar 2025’, Huons Meditech was actively engaged in business meetings with local buyers and distributors, opening up new business opportunities. According to the company official, Huons Meditech has strengthened its presence in Brazil and also Latin America through this event.
CEO of Huons Meditech, Lee Jin-suk, said, “Hospitalar 2025 had established a strong foothold for Huons Meditech to advance into Latin America. We will further strengthen our position in the global medical device market by introducing the competitive advantages of our products at global events.”
Huons Meditech will participate World Health Expo Miami (WHX MIAMI 2025), to be held from June 11 to 13 in Miami, the U.S., to expand its reach to North America. ‘WHX MIAMI 2025’ connects the healthcare industry's best researchers, developers, innovators, dealers and distributors across North and Latin America.
Huons Group Chairman Yoon Sung-tae Attends in Inauguration of Endoscope Washer-Disinfector Production Line at India’s Vasu Group
Huons Meditech Showcases at ‘WHX Dubai 2026’
Huons Meditech Officially Launches ‘Dermashine Duo RF’, Combining Drug Delivery with Radiofrequency
Huons Meditech Participates in MEDICA 2025 in Germany
Huons Meditech Discusses Local Assembly Production Collaboration with India’s Vasu Group
Huons Meditech receives CE marking for Dermashine Pro
Huons Meditech offers a new paradigm for ESWT in urology
Huons Meditech drives global growth, participating in medical device symposiums in AU&US
Huons Meditech to showcase at Healthcare Trade Fair ‘Hospitalar 2025’ in Brazil
Huons Meditech receives Taiwan FDA approval for gynecological drug delivery system 'Jill'SOF'
Huons Group participates ‘Dubai Derma 2025’ for efforts to maximize sales
Huons Meditech officially launches Extracorporeal Shock Wave Therapy device ‘IMPO88 Plus’ for Erectile Dysfunction - Proven effect on Chronic Prostatitis/Chronic Pelvic Pain Syndrome Treatment -